- Wellington Partners is a pan-European venture capital firm, founded in 1998, with around €800 million under management and offices in London, Munich and Zurich.
- The firm invests in young companies throughout Europe, mainly in the areas of technology, life sciences and digital media (e.g. interactive TV, gaming, Web 2.0).
About Wellington Partners
In 1991, Rolf Dienst founded Wellington Partners after he had built one of the first – and still one of the largest – German venture capital firms, TVM Capital, during the 1980s. In 1998, Wellington Partners closed its first fund, Wellington Partners I. Two years later, the firm closed its second fund on €210 million. After considering suggestions from investors, Wellington Partners initiated its first pure technology fund with €150 million in 2004 and its first life sciences fund in 2006. At the beginning of 2008, the company closed its latest technology fund at €265 million.
As of 2019 this technology division of the company had invested € 640 million in 120 companies across Europe. WP Tech has offices in Munich, London and Zurich. This part of the company as of 2019 was not making new investments in technology companies and was focused on value creation.
Wellington Partners Life Sciences division invests in early- and growth-stage life science companies, mainly in Europe, in amounts from €2m up to €20m over the life of the investment. Their focus is in therapeutics, medtech, diagnostics, digital health and biotechnology. As of 2019 more than € 400 million of funds raised were dedicated to life sciences.
More from VCs
Wellington Partners Portfolio
Wellington Partners has made 213 investments. Their most recent investment was on April 22, 2021, when Onward, a Dutch firm who have developed an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools, raised €26.5M in a venture funding round.
Wellington Partners has made 3 diversity investments. Their most recent diversity investment was on March 2, 2021, when EGenesis, who leverage genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs, raised $125M in a Series C funding round.
Wellington Partners has had 51 exits. Wellington Partners’s most notable exits include UiPath, Spotify, and FREE NOW.
Do you need funding for your business or startup? TechRound works with a panel of VCs and Angel Investors. Enquire today >>